MD Anderson Cancer Center and Ascentage Pharma announce strategic alliance in cancer drug development

(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Ascentage Pharma Group, Inc. today announced a five-year strategic collaboration agreement to advance the development of five potential new cancer therapies.